TMCnet News
Research and Markets: Global Peripheral Artery Occlusive Disease (PAOD) Therapeutics Pipeline Review 2014 - Analysis of 5 Companies & 5 Drug ProfilesDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/kffcvv/peripheral_artery) has announced the addition of the "Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Peripheral Artery Occlusive Disease (PAOD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peripheral Artery Occlusive Disease (PAOD) and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strateges to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope
Companies Involved in Therapeutics Development
Drug Profiles
For more information visit http://www.researchandmarkets.com/research/kffcvv/peripheral_artery
|